Exxon Mobil, Chemed, Las Vegas Sands And More On CNBC's 'Final Trades'

Comments
Loading...
Zinger Key Points
  • Exxon Mobil's asset sale deal with Seplat Energy in Nigeria could be approved in a few days.
  • Chemed will release financial results for the third quarter ended Sept. 30 on Tuesday, Oct. 29.
  • Get Monthly Picks of Market's Fastest Movers

On CNBC's “Halftime Report Final Trades,” Joshua Brown of Ritholtz Wealth Management picked iShares U.S. Oil & Gas Exploration & Production ETF IEO saying oil stocks are his hedge against escalating conflict with Iran.

Jim Lebenthal of Cerity Partners said Exxon Mobil Corporation XOM is having a great year and is 3% away from its all-time high.

Exxon Mobil’s asset sale deal with Seplat Energy in Nigeria could be approved soon. On Tuesday, Nigeria's President, Bola Ahmed Tinubu, said, "As such, the ExxonMobil Seplat divestment will receive ministerial approval in a matter of days, having been concluded by the regulator, NUPRC, in line with the Petroleum Industry Act, PIA." 

Don't forget to check out our premarket coverage here

Kari Firestone of Aureus Asset Management named Chemed Corporation CHE as her final trade.

Chemed will release financial results for the third quarter ended Sept. 30 on Tuesday, Oct. 29, after the closing bell on the New York Stock Exchange.

Stephanie Link of Hightower picked Las Vegas Sands Corp. LVS, a China play.

On Oct. 1, Wells Fargo analyst Daniel Politzer maintained Las Vegas Sands with an Overweight rating and raised the price target from $53 to $60.

Price Action:

  • iShares U.S. Oil & Gas Exploration & Production ETF gained 2.2% during Tuesday's session.
  • Exxon Mobil shares gained 2.3% to settle at $119.93 on Tuesday.
  • Chemed shares fell 1.4% to close at $592.79 during Tuesday's session.
  • Las Vegas Sands shares gained 3% to close at $51.83 on Tuesday.

Check This Out:

Image: Shutterstock

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!